CH410931A - Process for the preparation of 5-oxy-dibenzocycloheptene derivatives - Google Patents
Process for the preparation of 5-oxy-dibenzocycloheptene derivativesInfo
- Publication number
- CH410931A CH410931A CH78965A CH7896560A CH410931A CH 410931 A CH410931 A CH 410931A CH 78965 A CH78965 A CH 78965A CH 7896560 A CH7896560 A CH 7896560A CH 410931 A CH410931 A CH 410931A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- bridge
- preparation
- oxy
- dibenzo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 5
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MSRGJHYCGFYETG-UHFFFAOYSA-N 2-[2-(4-methylphenyl)ethyl]benzoic acid Chemical compound C1=CC(C)=CC=C1CCC1=CC=CC=C1C(O)=O MSRGJHYCGFYETG-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000007269 dehydrobromination reaction Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MJGFBOZCAJSGQW-UHFFFAOYSA-N mercury sodium Chemical compound [Na].[Hg] MJGFBOZCAJSGQW-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001023 sodium amalgam Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/33—Polycyclic acids
- C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von 5-Oxy-dibenzocycloheptenderivaten
Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 5-Oxydibenzocycloheptenderivaten der Formel
EMI1.1
worin Rt und R2 je Wasserstoff, Halogen oder eine Alkylgruppe von 14 Kohlenstoffatomen, aber nicht beide Wasserstoffatome bedeuten.
Die neuen Verbindungen besitzen eine biocide Wirkung. Sie sind auch wertvoll als Ausgangsprodukte zur Herstellung von Verbindungen der Formel
EMI1.2
in der Y eine gerade oder verzweigte, gegebenenfalls durch ein Sauerstoffatom unterbrochene
Kohlenstoffkette mit höchstens 6 Kohlen stoffatomen ist, und
Z eine Dialkylaminogruppe vorstellt, in dar eine oder beideAlkylgruppen zusammen mit dem Stickstoffatom und gegebenenfalls mit der Kohlenstoffkette Y einen oder mehrere heterocyclische Ringe darstellen können, in denen ausser diesem Stickstoffatom noch ein zweites Heteroatom enthalten sein kann.
Die letzterwähnten Substanzen haben u. a. eine starke antihistaminische Aktivität und Antiacetylcholinwirkung.
Als Halogensubstituenten kommen insbesondere Chlor und Brom und als Alkylgruppen besonders Methyl, Äthyl, Propyl, Isopropyl, Butyl und tert.
Butyl in Betracht.
Das erfindungsgemässe Verfahren zur Herstellung von Verbindungen der Formel list dadurch gekennzeichnet, dass man in einer Verbindung der Formel
EMI1.3
in beliebiger Reihenfolge einerseits die -CH2-CH2- Brücke zwischen den beiden Phenylringen in eine -CH=CH-Brücke überführt und andererseits zum entsprechenden Alkohol reduziert.
Für die Überführung Ider gesättigten in eine ungesättigte Brücke ist eine Behandlung mit N-Bromsuccinimid und anschliessende Entziehung von Bromwasserstoff besonders geeignet. Diese Verfahrensstufe, welche vorzugsweise zuerst durchgeführt wird, kann man zweckmässig in Gegenwart eines inerten organischen Lösungsmittels, z. B. Tetrachlorkohlenstoff, durchführen. Auch die Dehydrobromierung erfolgt zweckmässig am gelösten, bzw. dispergierten Monobromprodukt. Es empfiehlt sich dabei eine organische Base zu benutzen, die nicht nur als Lösungs- bzw.
Dispersionsmittel, sondern auch als Akzeptor für die abgespaltene Säure dienen kann. Am besten eignet sich für diese Zwecke das Pyridin.
Die Reduktion des Ketons kann nach den dazu üblichen Methoden durchgeführt werden.
Den erfindungsgemäss erhältlichen Carbinolen entsprechende Verbindungen, in denen die Phenylkerne nicht substituiert sind, waren bereits bekannt.
Davon wurde Dibenzo-(a,d)- 1 ,4-cycloheptadienol-5 vom F. 90 C von H. J. Klinkhammer, Dissertation, Universität Leipzig (1951), und von W. Treibs und H. J. Klinkhammer, Ber. 84, 671 (1951) beschrieben.
Dibenzo-(a, e)-1, 3, 5-cycloheptatrienol-5 wurde von Treibs und Klinkhammer, a. a. 0. beschrieben, die als F. 980 C angeben, und auch von G. Berti, Gazz.
Chim. Ital. 87, 293 (1957), und J. Org. Chem. 22, 230 (1957), der 1200 C als Schmelzpunkt angibt.
Sofern die neuen Verbindungen als Heilmittel benutzt werden, können sie mit geeigneten Trägern gemischt und in die zur Verabreichung geeignete Form gebracht werden.
Beispiel 1
In einem Kolben von 500 ml Inhalt werden 110 ml eines 850/oigen Phosphorsäuresirups bei 80" C unter Rühren mit 160 g P205 versetzt. Die Temperatur des Gemisches wird noch 1 Stunde auf 1000 C gehalten, worauf weiter bis auf 1700 C erhitzt wird.
Bei dieser Temperatur werden unter sehr kräftigem Rühren 50 g 1-(p-Tolyl)-2-(o-carboxyphenyl)-äthan in kleinen Portionen zugesetzt, wonach noch 4 Stunden bei derselben Temperatur gerührt wind.
Nach Abkühlen wird der Inhalt des Kolbens auf Eiswasser ausgegossen. Die Masse wird noch t/2 Stunde gerührt und mit Äther extrahiert. Die ätherische Lösung wird mit einer 2n-Sodalösung und mit Wasser gewaschen. Nach Trocknen und Abdampfen des äther wird der Rückstand im Vakuum fraktioniert destilliert. Es wird 3-Methyl-dibenzo (a,d)-1,4-cycloheptadien-on-(5), Kp. = 165-1670 C/ 2 mm in 810/oiger Ausbeute erhalten.
In einem Kolben von 100 ml wird ein Gemisch aus 6,7 g 3 -Methyl-dibenzo-(a,d)-1 ,4-cycloheptadienon-(5), 5,3 g N-Brom-succinimid und 0, 1 g Benzoyl peroxid d in 25 ml Tetrachlorkohlenstoff zwei Stunden unter Rückflusskühlung gekocht. Nach Abkühlen wird das Succinimid abfiltriert, wonach eingedampft wird. Die zurückbleibende Monobromverbindung kann aus Petroläther (Kp. 60-80 C) kristallisiert werden.
6,4 g des bromierten Produktes werden mit 20 ml Pyridin erhitzt, wonach das Gemisch in 250 ml
2n-Salzsäure ausgegossen wird. Der Niederschlag wird abfiltriert und aus Petroläther (Schmelzpunkt 60-80 C) kristallisiert. Ausbeute an 3-Methyl dibenzo-(a;e)- 1,3 ,5-cycloheptatrienon-(5) 78 O/o.
Schmelzpunkt 80-81 C.
10 g 3-Methyl-dibenzo-(a, e)-1, 3, 5-cycloheptatrie- non-(5) werden in 150 ml 960/oigem Äthanol gelöst und während 20 Stunden am Rückflusskühler mit 2 kg 0,50/obigem Natrium am algam gekocht. Die alkoholische Lösung wird in mit 3n-Essigsäure angesäuertes Eiswasser gegossen. Der gebildete Niederschlag wird abfiltriert, getrocknet und aus Petrol äther oder Benzin kristallisiert. Es werden 7,5 g 3-Methyl-dibenzor (a, e) - 1,3, 5-cycloheptatrienol-(5) vom Schmelzpunkt 1l8-119,50C erhalten. Ausbeute 75 O/o.
Beispiel 2
Man stellt 3-Brom-dibentzo-[a, d]-1, ,4-cyclohepta- dien-on-(5) her, indem man 5,0 g l-(p-Bromphenyl) 2-(o-carboxyphenyl)-äthan in 5,7 g Thionylchlorid löst und die Lösung während 3 Stunden am Rückflusskühler kocht. Das überschüssige Thionylchlorid wird abdestilliert und das verbleibende Ül in 30 ml CS gelöst.
Die Lösung wird zu 4,3 g A1 C13 in 50 ml CS2 gegeben. Es entwickelt sich Salzsäuregas. Das Reaktionsgemisch wird während 8 Stunden unter Rückfluss erhitzt, dann abgekühlt und auf Eis und Salzsäure gegossen. Nach Benzolzusatz wird filtriert, die organische Schicht abgetrennt, mit Natronlauge und Wasser gewaschen und über Glaubersalz getrocknet.
Das nach Abdestillieren des Lösungsmittels verbleibende Öl gibt bei Zusatz von Methanol das 3-Brom dibenzo-[a,d]- 1 4-cycloheptadien 1',4')-on-(5) als kristallinische Masse.
In einem 100 ml Kolben wird ein Gemisch aus 8,6 g des erhaltenen 3-Brom-dibenzo-[a,d]-1,4-cyclo- heptadien-(l',4')-ons-(5), 5,3 g N-Brom-succinimid und 0,1 g Benzoylperoxyd in 30 ml Tetrachlorkohlenstoff 2 Stunden unter Rückflusskühlung gekocht.
Nach Abkühlung auf Zimmertemperatur wird das gefällte Succinimid abfiltriert und das Lösungsmittei abdestilliert. Das gebildete Dibromid kann aus Petrol äther umkristallisiert werden. 9,1 g des Dibromids werden mit 30 ml Pyridin erhitzt und das Gemisch in 300 ml 2n-Salzsäur, e gegossen. Der Niederschlag wird filtriert und aus Petroläther umkristallisiert. Man erhält 3 -Brom-dibenzo(a,e)-l,3,5-cycloheptatrien on-(5) in 740/oiger Ausbeute. Fp. = 111 bis 1120 C.
8,5 g 3-Brom-dibenzo(a,e)-1 1,3 ,5-cycloheptatrien- on-(5) werden in 140 ml Äthanol gelöst und mit 2 kg Natriumamalgam (0,5 O!o) während 20 Stunden unter Rückflusskühlung gekocht. Die alkoholische Lösung wird in Eiswaser, das mit 3n-Essigsäure angesäuert ist, ausgegossen. Der gebildete Niederschlag wird abfiltriert, getrocknet und aus Petroläther oder Benzin umkristallisiert.
Process for the preparation of 5-oxy-dibenzocycloheptene derivatives
The invention relates to a process for the preparation of new 5-oxydibenzocycloheptene derivatives of the formula
EMI1.1
where Rt and R2 each represent hydrogen, halogen or an alkyl group of 14 carbon atoms, but not both hydrogen atoms.
The new compounds have a biocidal effect. They are also valuable as starting materials for the production of compounds of the formula
EMI1.2
in which Y is a straight or branched one, optionally interrupted by an oxygen atom
Is a carbon chain with a maximum of 6 carbon atoms, and
Z represents a dialkylamino group in which one or both alkyl groups together with the nitrogen atom and optionally with the carbon chain Y can represent one or more heterocyclic rings in which, in addition to this nitrogen atom, a second heteroatom can also be contained.
The last-mentioned substances have u. a. a strong antihistamine activity and antiacetylcholine effect.
Halogen substituents are in particular chlorine and bromine and alkyl groups are particularly methyl, ethyl, propyl, isopropyl, butyl and tert.
Butyl into consideration.
The inventive method for the preparation of compounds of the formula list, characterized in that in a compound of the formula
EMI1.3
in any order on the one hand the -CH2-CH2- bridge between the two phenyl rings is converted into a -CH = CH bridge and on the other hand it is reduced to the corresponding alcohol.
A treatment with N-bromosuccinimide and subsequent removal of hydrogen bromide is particularly suitable for converting the saturated to an unsaturated bridge. This stage of the process, which is preferably carried out first, can advantageously be carried out in the presence of an inert organic solvent, e.g. B. carbon tetrachloride perform. The dehydrobromination also expediently takes place on the dissolved or dispersed monobromo product. It is advisable to use an organic base that is not only used as a solvent or
Dispersant, but also can serve as an acceptor for the split off acid. Pyridine is best suited for this purpose.
The reduction of the ketone can be carried out by the methods customary for this purpose.
Compounds corresponding to the carbinols obtainable according to the invention, in which the phenyl nuclei are not substituted, were already known.
Of these, dibenzo- (a, d) -1, 4-cycloheptadienol-5 from F. 90 C by H. J. Klinkhammer, dissertation, University of Leipzig (1951), and by W. Treibs and H. J. Klinkhammer, Ber. 84, 671 (1951).
Dibenzo- (a, e) -1, 3, 5-cycloheptatrienol-5 was by Treibs and Klinkhammer, a. a. 0., which indicate as F. 980 C, and also by G. Berti, Gazz.
Chim. Ital. 87, 293 (1957) and J. Org. Chem. 22, 230 (1957), which gives 1200 ° C. as the melting point.
If the new compounds are used as medicaments, they can be mixed with suitable carriers and brought into the form suitable for administration.
example 1
In a flask with a capacity of 500 ml, 160 g of P205 are added to 110 ml of an 850% phosphoric acid syrup at 80 ° C. while stirring. The temperature of the mixture is maintained at 1000 ° C. for a further hour, after which it is heated up to 1700 ° C.
At this temperature 50 g of 1- (p-tolyl) -2- (o-carboxyphenyl) ethane are added in small portions with very vigorous stirring, after which the mixture is stirred for a further 4 hours at the same temperature.
After cooling, the contents of the flask are poured onto ice water. The mass is stirred for a further t / 2 hour and extracted with ether. The ethereal solution is washed with a 2N soda solution and with water. After drying and evaporation of the ether, the residue is fractionally distilled in vacuo. 3-Methyl-dibenzo (a, d) -1,4-cycloheptadien-one- (5), boiling point = 165-1670 C / 2 mm, is obtained in a yield of 810%.
A mixture of 6.7 g of 3-methyl-dibenzo- (a, d) -1, 4-cycloheptadienone- (5), 5.3 g of N-bromosuccinimide and 0.1 g is placed in a 100 ml flask Benzoyl peroxide d boiled under reflux for two hours in 25 ml of carbon tetrachloride. After cooling, the succinimide is filtered off and it is evaporated. The remaining monobromo compound can be crystallized from petroleum ether (boiling point 60-80 ° C.).
6.4 g of the brominated product are heated with 20 ml of pyridine, after which the mixture is dissolved in 250 ml
2N hydrochloric acid is poured out. The precipitate is filtered off and crystallized from petroleum ether (melting point 60-80 ° C.). Yield of 3-methyl dibenzo- (a; e) -1,3,5-cycloheptatrienone- (5) 78 O / o.
Melting point 80-81 C.
10 g of 3-methyl-dibenzo- (a, e) -1, 3, 5-cycloheptatrienon- (5) are dissolved in 150 ml of 960% ethanol and added for 20 hours on the reflux condenser with 2 kg of 0.50 / above Sodium cooked on algam. The alcoholic solution is poured into ice water acidified with 3N acetic acid. The precipitate formed is filtered off, dried and crystallized from petroleum ether or gasoline. 7.5 g of 3-methyl-dibenzor (a, e) -1,3,5-cycloheptatrienol- (5) with a melting point of 18-119.50 ° C. are obtained. Yield 75%.
Example 2
3-Bromo-dibentzo- [a, d] -1,, 4-cycloheptadien-one- (5) is prepared by adding 5.0 g of l- (p-bromophenyl) 2- (o-carboxyphenyl) -ethane dissolves in 5.7 g of thionyl chloride and the solution boils on the reflux condenser for 3 hours. The excess thionyl chloride is distilled off and the remaining oil is dissolved in 30 ml of CS.
The solution is added to 4.3 g of A1 C13 in 50 ml of CS2. Hydrochloric acid gas develops. The reaction mixture is refluxed for 8 hours, then cooled and poured onto ice and hydrochloric acid. After addition of benzene, it is filtered, the organic layer is separated off, washed with sodium hydroxide solution and water and dried over Glauber's salt.
The oil remaining after the solvent has been distilled off gives the 3-bromo dibenzo- [a, d] -1 4-cycloheptadiene 1 ', 4') - on- (5) as a crystalline mass when methanol is added.
In a 100 ml flask, a mixture of 8.6 g of the 3-bromo-dibenzo- [a, d] -1,4-cyclo-heptadiene- (1 ', 4') - ons- (5), 5 , 3 g of N-bromosuccinimide and 0.1 g of benzoyl peroxide in 30 ml of carbon tetrachloride are boiled under reflux for 2 hours.
After cooling to room temperature, the precipitated succinimide is filtered off and the solvent is distilled off. The dibromide formed can be recrystallized from petroleum ether. 9.1 g of the dibromide are heated with 30 ml of pyridine and the mixture is poured into 300 ml of 2N hydrochloric acid. The precipitate is filtered off and recrystallized from petroleum ether. 3-Bromo-dibenzo (a, e) -l, 3,5-cycloheptatrienone- (5) is obtained in 740% yield. Mp = 111 to 1120 C.
8.5 g of 3-bromo-dibenzo (a, e) -1 1,3,5-cycloheptatrien- one- (5) are dissolved in 140 ml of ethanol and treated with 2 kg of sodium amalgam (0.5 O! O) for 20 Boiled under reflux for hours. The alcoholic solution is poured into ice water that has been acidified with 3N acetic acid. The precipitate formed is filtered off, dried and recrystallized from petroleum ether or gasoline.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL237663 | 1959-04-01 | ||
| US277013A US3209007A (en) | 1959-04-01 | 1963-04-30 | (dibenzo (a, d) 1, 4-cycloheptene-5-yloxy) amines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH410931A true CH410931A (en) | 1966-04-15 |
Family
ID=31497751
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH351160A CH400108A (en) | 1959-04-01 | 1960-03-29 | Process for the preparation of 5-oxydibenzocycloheptane derivatives |
| CH78965A CH410931A (en) | 1959-04-01 | 1960-03-29 | Process for the preparation of 5-oxy-dibenzocycloheptene derivatives |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH351160A CH400108A (en) | 1959-04-01 | 1960-03-29 | Process for the preparation of 5-oxydibenzocycloheptane derivatives |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3209007A (en) |
| CH (2) | CH400108A (en) |
| DE (1) | DE1470127A1 (en) |
| DK (1) | DK106732C (en) |
| FR (1) | FR3745M (en) |
| GB (1) | GB943604A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1091910A (en) * | 1964-08-18 | 1967-11-22 | Koninklijke Pharma Fab Nv | New dibenzocycloheptenylamines |
| US4569944A (en) * | 1984-06-21 | 1986-02-11 | Warner-Lambert Company | Dibenzosuberone as a non-steroidal anti-inflammatory compound and compositions thereof |
-
1960
- 1960-03-29 CH CH351160A patent/CH400108A/en unknown
- 1960-03-29 CH CH78965A patent/CH410931A/en unknown
- 1960-04-01 GB GB11550/60A patent/GB943604A/en not_active Expired
-
1963
- 1963-04-30 US US277013A patent/US3209007A/en not_active Expired - Lifetime
- 1963-10-09 DK DK474263AA patent/DK106732C/en active
- 1963-10-18 DE DE19631470127 patent/DE1470127A1/en active Pending
- 1963-11-12 FR FR953340A patent/FR3745M/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CH400108A (en) | 1965-10-15 |
| GB943604A (en) | 1963-12-04 |
| US3209007A (en) | 1965-09-28 |
| DK106732C (en) | 1967-03-13 |
| FR3745M (en) | 1965-12-13 |
| DE1470127A1 (en) | 1969-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2201889A1 (en) | ARYLPIPERAZINE AND THE PROCESS FOR THEIR PRODUCTION | |
| DE949105C (en) | Process for the production of new, fungicidal and protozoocidal aromatic aminoketones and their salts | |
| CH410931A (en) | Process for the preparation of 5-oxy-dibenzocycloheptene derivatives | |
| DE934651C (en) | Process for the preparation of tetrasubstituted diaminoalkanes | |
| US2533086A (en) | Hydroxymethylthianaphthene | |
| AT236947B (en) | Process for the preparation of new imidazole derivatives | |
| CH438352A (en) | Process for the preparation of diphenylalkylamines | |
| AT203485B (en) | Process for the production of new dinitrophenyl methacrylates | |
| AT222637B (en) | Process for the preparation of new dibenzocycloheptane derivatives | |
| CH413825A (en) | Process for the production of new amines | |
| AT228217B (en) | Process for the preparation of new homothioxanthene derivatives | |
| AT244327B (en) | Process for the preparation of diphenylalkylamines and their physiologically acceptable salts | |
| CH532005A (en) | Phenoxyacetic acids - useful for treating congestive heart failure | |
| AT247847B (en) | Process for the preparation of new 5- (3'-aminopropylidene) -5H-dibenzo [a, d] cycloheptenes or the 10, 11-dihydro derivatives thereof | |
| DE1768644C (en) | Process for the production of acrylophenones | |
| DE870106C (en) | Process for the production of negatively substituted condensation products | |
| DE513204C (en) | Process for the preparation of condensation products from aromatic hydrocarbons | |
| AT228804B (en) | Process for the preparation of thionothiol phosphoric acid esters | |
| AT259553B (en) | Process for the production of indole derivatives | |
| AT227713B (en) | Process for the preparation of new 1,5-diazacyclooctane derivatives | |
| AT243268B (en) | Process for the preparation of new benzoquinolizine derivatives | |
| AT226692B (en) | Process for the preparation of new α-pyrrolidino-valerophenones | |
| AT233016B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT218010B (en) | Process for the preparation of basic aralkyl nitriles | |
| AT227712B (en) | Process for the preparation of new 1,5-diazacyclooctane derivatives |